Advertisement

Reply

Published:November 09, 2022DOI:https://doi.org/10.1016/j.ajogmf.2022.100807
      We thank Dr. El-Qushayri for his interest in our paper1. The recent outbreaks of monkeypox infection have highlighted the need for a specific knowledge of the impact of such infection on pregnant individuals and their infants. In May 2022, multiple cases of monkeypox were identified in several non-endemic countries, mainly United Kingdom and, in July 23rd, 2022, the World Health Organization (WHO) declared monkeypox a global health emergency. Although the course of monkeypox infection is often self-limiting, there is lack of objective data on its course in pregnancy. Previous data on smallpox infection, a virus belonging to the same family of Monkeypox, in pregnancy have suggested a heightened risk of adverse maternal and perinatal outcomes. In our review, we reported a relatively high risk of adverse fetal, but not maternal outcome, in pregnancies complicated by Monkeypox infection. Only seven cases of pregnant women were included in the review. Regarding the potential inclusion of duplicates cases in the studies by Ogoina et al, and Yinka-Ogunleye et.2,3, we contacted the authors before including these cases in our review and we did not receive any information suggestive of duplicate cases in these studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect